Literature DB >> 11167928

Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome.

M Elsheikh1, B Casadei, G S Conway, J A Wass.   

Abstract

Women with Turner's syndrome (TS) have a threefold increase in mortality, primarily as a result of their cardiovascular complications. Recently, the risk of fatal aortic dissection has come to light as a major cause of mortality in women with TS. The aim of this study was to assess the prevalence of aortic root dilatation in a group of women with TS and to investigate the factors contributing to its development. Thirty-eight women with TS attending a dedicated adult Turner clinic were examined clinically and by M-mode and two-dimensional echocardiography on at least one occasion. Aortic root dilatation was defined as an aortic root diameter greater than the 95th centile for body surface area. Fasting serum lipid concentrations were measured in all women. Additionally, 18 subjects underwent noninvasive assessment of central arterial stiffness using applanation tonometry. Fifty percent of subjects were hypertensive and a similar number had an abnormal echocardiogram. A bicuspid aortic valve was present in 33% of subjects, 16 women (42%) had ascending aortic root dilatation. This was associated with a bicuspid aortic valve in four women and hypertension in 11. Two women had isolated aortic root dilatation. Aortic root diameter was significantly associated with systolic blood pressure (r = 0.5, P = 0.003) and left ventricular thickness (r = 0.5, P = 0.02). There was no association with serum lipids or arterial compliance. Structural cardiac abnormalities are present in up to 50% of women with Turner's syndrome. Aortic root dilatation is a significant risk in women with Turner's syndrome and is closely dependent on blood pressure. Aortic root dilatation does not appear to be related to atherosclerosis and is more likely to be due to a mesenchymal defect. Regular surveillance of the aortic root diameter is essential in all women with Turner's syndrome and hypertension should be treated aggressively when present in order to minimize the risk of potentially fatal aortic dissection.

Entities:  

Mesh:

Year:  2001        PMID: 11167928     DOI: 10.1046/j.1365-2265.2001.01154.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  34 in total

1.  Failure of Marfan anatomic criteria to predict risk of aortic dissection in Turner syndrome: necessity of specific adjusted risk thresholds.

Authors:  Juan-Pablo Maureira; Fabrice Vanhuyse; Malik Lekehal; Thierry Hubert; Charlène Vigouroux; Marie-Françoise Mattei; Daniel Grandmougin; Jean-Pierre Villemot
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-26

2.  Aortic dilatation in Turner syndrome: the role of MRI in early recognition.

Authors:  François Chalard; Solène Ferey; Cécile Teinturier; Gabriel Kalifa
Journal:  Pediatr Radiol       Date:  2004-12-29

Review 3.  New issues in the diagnosis and management of Turner syndrome.

Authors:  Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 4.  Optimising management in Turner syndrome: from infancy to adult transfer.

Authors:  M D C Donaldson; E J Gault; K W Tan; D B Dunger
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

5.  Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature.

Authors:  M Carlson; M Silberbach
Journal:  BMJ Case Rep       Date:  2009-07-01

Review 6.  Open Versus Endovascular or Hybrid Thoracic Aortic Aneurysm Repair.

Authors:  Ryan Clare; Julianne Jorgensen; Somjot S Brar
Journal:  Curr Atheroscler Rep       Date:  2016-10       Impact factor: 5.113

Review 7.  Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature.

Authors:  M Carlson; M Silberbach
Journal:  J Med Genet       Date:  2007-09-14       Impact factor: 6.318

8.  Abnormal aortic arch morphology in Turner syndrome patients is a risk factor for hypertension.

Authors:  Katya De Groote; Daniël Devos; Koen Van Herck; Laurent Demulier; Wesley Buysse; Jean De Schepper; Daniël De Wolf
Journal:  Heart Vessels       Date:  2014-06-17       Impact factor: 2.037

9.  Impaired Vascular Function of the Aorta in Adolescents with Turner Syndrome.

Authors:  Hyo Soon An; Jae Suk Baek; Gi Beom Kim; Young Ah Lee; Mi Kyoung Song; Bo Sang Kwon; Eun Jung Bae; Chung Il Noh
Journal:  Pediatr Cardiol       Date:  2016-09-15       Impact factor: 1.655

10.  Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study.

Authors:  Britta E Hjerrild; Kristian H Mortensen; Keld E Sørensen; Erik M Pedersen; Niels H Andersen; Erik Lundorf; Klavs W Hansen; Arne Hørlyck; Alfred Hager; Jens S Christiansen; Claus H Gravholt
Journal:  J Cardiovasc Magn Reson       Date:  2010-03-11       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.